ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Revenue

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndRevenue (Million USD)YoY (%)
Dec 31, 202544,328+5.67%
Dec 31, 202441,950+4.59%
Dec 31, 202340,109-8.12%
Dec 31, 202243,653+1.34%
Dec 31, 202143,075+24.47%
Dec 31, 202034,608+8.48%
Dec 31, 201931,904+4.34%
Dec 31, 201830,578+11.64%
Dec 31, 201727,390+31.35%
Dec 31, 201620,853+2.20%
Dec 31, 201520,405-6.60%
Dec 31, 201321,848-43.77%
Dec 31, 201138,851+10.48%
Dec 31, 201035,167

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat